ACR exact-submission catalog context
ACR AI Central provides an exact-submission model card for Al-Rad Companion (Pulmonary); FDA labeling remains controlling for clinical use, limitations, and performance.
exact submission · checked 2026-09-09FDA-cleared profile
Siemens Medical Solutions USA, Inc. · CT/CTA · FDA-cleared (510(k))
Authorized purpose: Quantitative and qualitative CT analysis to support radiologists and physicians in emergency medicine, specialty care, urgent care, and general practice in evaluating and assessing lung disease.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Quantitative and qualitative CT analysis to support radiologists and physicians in emergency medicine, specialty care, urgent care, and general practice in evaluating and assessing lung disease.
Evidence takeaway. Evidence from the reviewed source record: Non-clinical integration and functional testing was acceptable. Lung-lobe segmentation was validated on 250 datasets with average Dice coefficients from 0.94 to 0.96. Opaque-region segmentation was validated on 150 datasets, with 93.0% of opacity-percentage values within 95% limits of agreement based on interreader variability; subgroup and technical-parameter analyses reported consistent performance. These are Dice and limits-of-agreement endpoints, not sensitivity or specificity.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
This field has not been curated yet.
This field has not been curated yet.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Price not public here; enter your quote
Not verified: Pricing information is recorded but not verified against a resolving source.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Previously acquired CT DICOM images; only DICOM images of adult patients are valid input. Validation covered Siemens Healthineers data with filtered-backprojection and iterative reconstruction, GE Healthcare filtered-backprojection data, and Philips filtered-backprojection data.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-09 · FDA K213096: Al-Rad Companion (Pulmonary)
Source context, not route validation: The Al-Rad Companion Engine is the incoming and outgoing data interface; results are delivered to the clinical workplace in multiple formats including DICOM Structured Reports, and the Pulmonary extension provides an interface to external syngo.CT Lung CAD. VA13 supports teamplay cloud deployment and edge processing and result generation on-premises within the customer network, with the edge system connected to the cloud for remote monitoring and maintenance; specific local PACS or RIS compatibility is not established.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-09 · FDA K213096: Al-Rad Companion (Pulmonary)
Source context, not route validation: The exact FDA package describes AI-Rad Companion (Pulmonary) VA13 supporting cloud deployment hosted in the teamplay digital health platform and edge deployment processing data on-premises within the customer network, with the edge system connected to the cloud for remote monitoring and maintenance. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "The software version VA13 of the AI-Rad Companion (Pulmonary) includes the following modifications:" … "The system supports the existing cloud deployment as well as a new edge deployment. The system remains hosted in the teamplay digital health platform". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-11-14 · FDA K213096: Al-Rad Companion (Pulmonary)
Source context, not route validation: Segmentation and measurements of complete lungs and lobes; low-Hounsfield-value region identification; lung-lesion segmentation, measurement, and lobe assignment; elevated-opacity distinction; pulmonary-density percentages and ranges; bidirectional lesion diameter; DICOM Structured Report measurement results; and an interface to external syngo.CT Lung CAD.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-09 · FDA K213096: Al-Rad Companion (Pulmonary)
Unresolved route: Segmentation and measurements of complete lungs and lobes; low-Hounsfield-value region identification; lung-lesion segmentation, measurement, and lobe assignment; elevated-opacity distinction; pulmonary-density percentages and ranges; bidirectional lesion diameter; DICOM Structured Report measurement results; and an interface to external syngo.CT Lung CAD.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-09 · FDA K213096: Al-Rad Companion (Pulmonary)
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Packet wording: "The software version VA13 of the AI-Rad Companion (Pulmonary) includes the following modifications:" … "The system supports the existing cloud deployment as well as a new edge deployment. The system remains hosted in the teamplay digital health platform". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Vendor statement, not an attestation. Identity bridge: Siemens Healthineers' own corporate-info page names Siemens Medical Solutions USA, Inc. (Malvern, PA), and its 2024 governance press release states Siemens Healthcare GmbH's business was transferred to Siemens Healthineers AG. Corporate program statement; exact-release scope is not established.
Vendor statement, not an attestation. The page names Siemens Healthineers generally and does not scope these commitments to any specific product release; exact-release scope is not established.
ACR AI Central provides an exact-submission model card for Al-Rad Companion (Pulmonary); FDA labeling remains controlling for clinical use, limitations, and performance.
exact submission · checked 2026-09-09Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public price or quote for the exact K213096 configuration was established in this review.
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
8 sources - 3 history items
Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment
Scope: regulatoryIdentity, modalityContext
Scope: anatomy
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: postmarketSafety
Scope: security
Regulatory record
510(k)
Research record
fda record reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Agada Medical, Ltd.
Authorized purpose: Auto-Seg and Spine Auto-Seg accept spine and pelvis CT images and provide three-dimensional segmentation and labels to support spine-surgery planning and assessment by spine surgeons.
Brainomix Limited
Authorized purpose: Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.
Mighty Oak Medical
Authorized purpose: Acorn 3D Software and Acorn 3DP Model process CT, synthetic CT, and CT angiography for segmentation, visualization, measurement, treatment planning, and three-dimensional printing, including adult and pediatric spine trajectory planning.
Keya Medical Technology Co., Ltd.
Authorized purpose: Coronary plaque and stenosis quantification from CCTA
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history